Brightseed appoints new senior vice president of bioactives

Brightseed (San Francisco, CA) has appointed David Blackwood as senior vice president of bioactives, whose aim is to grow the company’s current IP-protected pipeline of bioactive ingredients while also expanding Brightseed’s portfolio of products for commercialization. Blackwood has 25 years of experience in nutrition, specialty chemicals, and specialty materials, previously serving as vice president of sales and marketing for DSM’s North American dietary supplement business, as well as vice president of global sales for PanTheryx.

David Blackwood, image courtesy of Brightseed

“David is a superb addition to the Brightseed team with the acumen to scale and realize the full potential of our novel bioactive ingredient pipeline that aims to set a new gold standard for the discovery and commercialization of science-backed functional ingredients,” said Brightseed CEO Jim Flatt, PhD, in a press release. “We’ve curated Brightseed’s pipeline to target broad consumer health areas of metabolic health, gut health and cognition. Our bioactive product pipeline accelerated by Forager AI will provide consumer-recognizable benefits, thereby improving overall health and wellness for millions."

“Our ability to harness the potential positive impact of food, plants, and ingredients on our health is growing exponentially with the introduction of innovative companies like Brightseed and the next-generation technology they bring to the table, paving the way to a healthier future,” said Blackwood. “I’m excited to be a part of the company bringing bioactives to the forefront of food and nutrition, with the ultimate goal of positively impacting consumer health and wellness.”